Abstract
The anticancer activity of mistletoe (Viscum album L.) lectins and proteins extracts has been demonstrated in numerous in vitro and in vivo studies, including the validation of their clinical efficacy. Mistletoe tissue culture has been suggested as an approach for standardizing lectin biosynthesis, while the biosynthesis of novel lectins through somaclonal variation, i.e. the epigenetic modulation of the genome in vitro has also been demonstrated. However, the tumor cytotoxic properties of these novel molecules have not been assessed. PC12 pheochromocytoma and RAW 264.7 macrophage cell cultures were treated with protein extracts from “normal” and somaclonally variant mistletoe callus cultures, as well as donor plants used as positive control. Mistletoe callus-derived extracts demonstrated a concentration-dependent cytotoxicity in cancer cell lines, which was significantly higher compared to donor plants. Extracts from somaclonal cultures were even more potent against tumor cells. Our results suggest that somaclonally variant mistletoe callus cultures could be used as potential cell factories for the production of novel anticancer proteins.
Keywords: Biotechnology, callus culture, cancer, in vitro cytotoxicity, mistletoe (Viscum album L.), somaclonal variation.
Graphical Abstract
Current Bioactive Compounds
Title:Protein Extracts from Somaclonal Mistletoe (Viscum Album L.) Callus with Increased Tumor Cytotoxic Activity in Vitro
Volume: 11 Issue: 2
Author(s): Maria Barberaki, Eirini Dermitzaki, Andrew N. Margioris, Maria Theodosaki, Stylianos Grafakos and Spyridon Kintzios
Affiliation:
Keywords: Biotechnology, callus culture, cancer, in vitro cytotoxicity, mistletoe (Viscum album L.), somaclonal variation.
Abstract: The anticancer activity of mistletoe (Viscum album L.) lectins and proteins extracts has been demonstrated in numerous in vitro and in vivo studies, including the validation of their clinical efficacy. Mistletoe tissue culture has been suggested as an approach for standardizing lectin biosynthesis, while the biosynthesis of novel lectins through somaclonal variation, i.e. the epigenetic modulation of the genome in vitro has also been demonstrated. However, the tumor cytotoxic properties of these novel molecules have not been assessed. PC12 pheochromocytoma and RAW 264.7 macrophage cell cultures were treated with protein extracts from “normal” and somaclonally variant mistletoe callus cultures, as well as donor plants used as positive control. Mistletoe callus-derived extracts demonstrated a concentration-dependent cytotoxicity in cancer cell lines, which was significantly higher compared to donor plants. Extracts from somaclonal cultures were even more potent against tumor cells. Our results suggest that somaclonally variant mistletoe callus cultures could be used as potential cell factories for the production of novel anticancer proteins.
Export Options
About this article
Cite this article as:
Barberaki Maria, Dermitzaki Eirini, N. Margioris Andrew, Theodosaki Maria, Grafakos Stylianos and Kintzios Spyridon, Protein Extracts from Somaclonal Mistletoe (Viscum Album L.) Callus with Increased Tumor Cytotoxic Activity in Vitro, Current Bioactive Compounds 2015; 11 (2) . https://dx.doi.org/10.2174/1573407211666150602215615
DOI https://dx.doi.org/10.2174/1573407211666150602215615 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sesterterpenoids with Anticancer Activity
Current Medicinal Chemistry Nano-Carriers of Combination Tumor Physical Stimuli-Responsive Therapies
Current Drug Delivery Glutathione Transferases: Emerging Multidisciplinary Tools in Red and Green Biotechnology
Recent Patents on Biotechnology Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Current Pharmaceutical Design Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
Current Medicinal Chemistry Anticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis
Cardiovascular & Hematological Agents in Medicinal Chemistry Screening Neuroprotective Agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation Induced PC12 Injury Models: A Review
Current Psychopharmacology Ceramide in Chemotherapy of Tumors
Recent Patents on Anti-Cancer Drug Discovery Meet Our Editorial Board Member
Current Cancer Therapy Reviews Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit
Current Neurovascular Research Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches
CNS & Neurological Disorders - Drug Targets Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Medicinal Chemistry Reviews - Online (Discontinued) Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) – a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Nucleic-Acid Delivery Using Lipid Nanocapsules
Current Pharmaceutical Biotechnology <i>In vivo</i> Anticancer Potential of Hydroxamic Acid Derivatives
Current Topics in Medicinal Chemistry Anticancer Mechanisms of Bioactive Peptides
Protein & Peptide Letters Antitumor Effects of Celastrol and Semi-Synthetic Derivatives
Mini-Reviews in Organic Chemistry Isolation, Structural Determination, and Evaluation of the Biological Activity of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol [20(S)-25-OCH3-PPD], a Novel Natural Product from Panax notoginseng
Medicinal Chemistry Current Non-viral Gene Therapy Strategies for the Treatment of Glioblastoma
Current Medicinal Chemistry A Systemic Approach to Cancer Treatment: Tumor Cell Reprogramming Focused on Endocrine-Related Cancers
Current Medicinal Chemistry